Galmed Pharmaceuticals Ltd
(STU:GPH)
€
4.86
0.000001 (0%)
Market Cap: 96.61 Mil
Enterprise Value: 83.95 Mil
PE Ratio: 0
PB Ratio: 0.15
GF Score: 36/100 Galmed Pharmaceuticals Ltd (STU:GPH) Transcripts
- Q4 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMay 02, 2022€23.25 (+9.15%)Earnings
- Q3 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptNov 08, 2021€37.8 (+5.00%)Earnings
- Q2 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptAug 05, 2021€35.1 (+1.74%)Earnings
- Q1 2021 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMay 13, 2021€27.6 (-3.16%)Earnings
- Q4 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMar 18, 2021€42.3 (-0.70%)Earnings
- Galmed Pharmaceuticals Ltd KOL Symposium and Pipeline Update TranscriptJan 26, 2021
- Q3 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptNov 12, 2020€40.8 (+4.62%)Earnings
- Q2 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptAug 06, 2020€61.8 (+0.98%)Earnings
- Q1 2020 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMay 14, 2020€66.9 (+4.69%)Earnings
- Q4 2019 Galmed Pharmaceuticals Ltd Earnings Call TranscriptMar 12, 2020€45.6 (-27.62%)Earnings
- Q3 2019 Galmed Pharmaceuticals Ltd Earnings Call TranscriptNov 06, 2019€62.4Earnings
- Q2 2019 Galmed Pharmaceuticals Ltd Earnings Call TranscriptAug 05, 2019Earnings
- 1